The deal priced below last closing price of $1.65. Canaccord is acting as lead book running manager for the offering.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LUCD:
- Closing Bell Movers: Futures sustaining gains after massive rebound
- Lucid Diagnostics announces common stock offering, no amount given
- Lucid Diagnostics Earnings Call Highlights Growth and Challenges
- Lucid Diagnostics price target lowered to $2 from $2.50 at BTIG
- Lucid Diagnostics: Strong Growth Potential Driven by Strategic Advancements and Market Expansion